The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute Columbus, Ohio
The Ohio State University Cancer Research Center was established in 1973 and received its NCI designation in April 1976 as a comprehensive cancer center (OSUCCC). The patient care arm of the OSUCCC is the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. The Center is known as the OSUCCC–James.
The OSUCCC–James is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 leading cancer centers that develops clinical practice guidelines to improve the quality of care.
There are six highly interactive cancer research programs at the Center: Experimental Therapeutics, Cancer Control, Innate Immunity, Molecular Biology and Cancer Genetics, Molecular Carcinogenesis and Chemoprevention, and Viral Oncology. Engaged in this research are more than 200 Center members from 11 of the 14 colleges at the University and affiliated academic institutions, including scientists and physicians from 16 specialties. Their work contributes to the Center’s larger mission to eradicate cancer from individuals’ lives by creating knowledge and integrating groundbreaking research with excellence in education and patient-centered care.
With the James Cancer Hospital, OSUCCC–James can rapidly translate the latest cancer research into innovative patient care. A multidisciplinary, high-technology and multimodality approach to cancer care includes disease site groups with surgical oncologists, medical oncologists, pathologists, radiologists, radiation oncologists, researchers and other experts collaborating to provide the latest in cancer diagnosis, treatment, and prevention. The hospital includes a bone marrow transplant unit, intraoperative radiation therapy, special isolation rooms, chemotherapy and special transfusion areas, and specialized diagnostic equipment. Every patient is matched with a team of experts from both cancer research and related areas of expertise.
This concentration of cancer research and care has led the OSUCCC–James to become one of only a few cancer centers approved by the NCI to conduct both Phase I and Phase II clinical trials for new anti-cancer drugs. Those trials take place in both inpatient and outpatient facilities at the Center.
Ambulatory patients access services from a variety of outpatient facilities on campus and across central Ohio. In 2011, a new ambulatory center will open near the campus that will house the OSUCCC–James Comprehensive Breast Program and other women-focused oncology programs. In 2014, a new James Cancer Hospital will open on the Ohio State Medical Center campus. In 2011, the OSUCCC–James will finalize the build-out of an additional 36,000 square feet of wet lab research space.
The OSUCCC–James’ outreach to underserved populations includes its work with the Appalachian Community Cancer Network and the effort undertaken by the Center for Population Health and Health Disparities to understand the reasons for high rates of cervical cancer incidence and mortality in Appalachian Ohio.
* This profile was provided by the Ohio State University Comprehensive Cancer Center.